Showing results (1501-1510 of 1,613) with videos related to

Sort By:
Pageof 162
JAMA Oncology|March 19, 2026
Bireociclib Plus Fulvestrant in Advanced Breast Cancer After Endocrine Progression: The BRIGHT-2 Phase 3 Randomized Clinical TrialJiayu Wang, Qingyuan Zhang, Huiping Li, et al.
JAMA Oncology|June 4, 2026
Treatment Delays in Early Age-Onset Colorectal CancerRyan T Heslin, Zachary A Whitham, Morgan F Pettigrew, et al.
JAMA Oncology|June 4, 2026
PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression: A Systematic Review and Meta-AnalysisAlessandro Di Federico, Samuele Compagno, Francesco Mantuano, et al.
JAMA Oncology|February 2, 2023
Breast Cancer Diagnosis, Treatment, and Outcomes of Patients From Sex and Gender Minority GroupsErik Eckhert, Olivia Lansinger, Victor Ritter, et al.
JAMA Oncology|June 4, 2023
Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung CancerLova Sun, Benjamin Bleiberg, Wei-Ting Hwang, et al.
JAMA Oncology|June 1, 2023
Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer: A Phase 3 Randomized Clinical TrialJoël Castelli, Juliette Thariat, Karen Benezery, et al.
JAMA Oncology|May 1, 2018
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance TrialErin L Van Blarigan, Charles S Fuchs, Donna Niedzwiecki, et al.
JAMA Oncology|May 21, 2026
Intraperitoneal and Intravenous Paclitaxel Plus S-1 for Gastric Cancer With Peritoneal Metastasis: A Phase 3 Randomized Clinical TrialChao Yan, Zhongyin Yang, Zheng Shi, et al.
JAMA Oncology|June 4, 2026
First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical TrialJingjing Liu, Liang Han, Lin Wu, et al.
JAMA Oncology|February 26, 2026
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 MutationsAndrea Napolitano, Heikki Joensuu, Sara Rothschild, et al.
Pageof 162